Pfs Partners, LLC Johnson & Johnson Transaction History

Pfs Partners, LLC

$177 Billion
Q3 2024

A detailed history of Pfs Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pfs Partners, LLC holds 1,003 shares of JNJ stock, worth $144,903. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,003

Previous 1,150 12.78%

Holding current value

$144,903

Previous $168 Million 3.26%

% of portfolio

0.09%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$145.48 - $167.38 $21,385 - $24,604	-147 Reduced 12.78%	1,003 $163 Million
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $9,817 - $10,729	-68 Reduced 5.58%	1,150 $168 Million
Q1 2024 Apr 15, 2024	SELL	$155.22 - $162.74 $1,707 - $1,790	-11 Reduced 0.9%	1,218 $193 Million
Q4 2023 Jan 26, 2024	BUY	$145.6 - $158.88 $582 - $635	4 Added 0.33%	1,229 $193 Million
Q3 2023 Nov 30, 2023	SELL	$155.75 - $174.48 $15,107 - $16,924	-97 Reduced 7.34%	1,225 $191 Million
Q2 2023 Nov 30, 2023	BUY	$154.35 - $166.11 $19,293 - $20,763	125 Added 10.44%	1,322 $219 Million
Q1 2023 Nov 30, 2023	BUY	$151.05 - $180.26 $2,114 - $2,523	14 Added 1.18%	1,197 $185 Million
Q4 2022 Nov 30, 2023	SELL	$160.2 - $179.79 $3.26 Million - $3.66 Million	-20,355 Reduced 94.51%	1,183 $209 Million
Q3 2022 Nov 30, 2023	BUY	$161.33 - $179.52 $483 - $538	3 Added 0.01%	21,538 $3.52 Billion
Q2 2022 Nov 30, 2023	BUY	$168.19 - $186.01 $504 - $558	3 Added 0.01%	21,535 $3.82 Billion
Q1 2022 Nov 30, 2023	SELL	$158.14 - $179.59 $21,981 - $24,963	-139 Reduced 0.64%	21,532 $3.82 Billion
Q4 2021 Nov 30, 2023	BUY	$155.93 - $173.01 $3.38 Million - $3.75 Million	21,671 New	21,671 $3.71 Billion

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.

Account